Briefing

The Briefing: Cloudbeds Closes $150M Series D, Prilenia Raises $43M, And More

Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know.

Subscribe to the Crunchbase Daily

Cloudbeds closes $150M Series D

San Diego-based hospitality platform Cloudbeds closed a $150 million Series D led by new investor SoftBank Vision Fund 2. The round also includes investments by Echo Street, Walleye Capital and returning investors Viking Global Investors, PeakSpan Capital and Counterpart Ventures.

Cloudbeds’ cloud-based hospitality management software integrates with host and independent hoteliers to give them tools to help with operations, revenue management, marketing and more.

Founded in 2012, Cloudbeds has now raised $253 million to date.

— Chris Metinko

Prilenia raises $43M

Prilenia Therapeutics, a  Dutch clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announced that it has raised $43 million in a Series B financing round led by Sands Capital, Forbion Capital Partners, and Morningside Venture Partners. The company is based in the Netherlands, Israel and Boston.

— Joanna Glasner

BrainCheck raises $10M Series B

Houston- and Austin-based BrainCheck, a provider of mobile interactive testing for cognitive health, raised $10 million in a Series B funding round led by Next Coast Ventures and S3 Ventures. The company’s platform is used in over 400 neurology, primary care and geriatrics practices involved in diagnosis and treatment of cognitive impairment and dementia.

— Joanna Glasner

Biotech

Gro Biosciences raises $25M: Boston-based Gro Biosciences, a biotechnology startup focused on protein therapeutics, raised $25 million in a Series A financing led by Leaps by Bayer and Redmile Group. The capital raised will go toward development of the GRO platform, expanded bioprocess manufacturing, and initial studies of its protein therapeutics to treat autoimmune and metabolic diseases.

— Joanna Glasner

Illustration: Dom Guzman

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Copy link